Register an account to search through 14,000+ stocks! 

ORGO – Organogenesis Holdings Inc

✔ COMPLIANT

★★★

Company Profile

Organogenesis Holdings Inc. is a regenerative medicine company, which is focused on the development, manufacture, and commercialization of solutions for the wound care and surgical and sports medicine markets. Its solutions address comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease, and smoking. The wound care products include Apligraf for the treatment of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs); Dermagraft for the treatment of diabetic foot ulcer (DFU); PuraPly AM and PuraPly XT as antimicrobial barriers for variety of wound types; and the Affinity and NuShield wound coverings to address a variety of wound sizes and types. Its surgical and sports medicine product includes ReNu for in-office knee osteoarthritis treatment; NuCel for bony fusion in the lumbar spine; NuShield and Affinity barrier products for surgical application in targeted soft tissue repairs; and PuraPly AM for management of open wounds in the surgical setting.

Business

PASS

Organogenesis Holdings Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard and its impure income is less than 5%. If you find this result mistaken or questionable, let us know in the comments.

Problematic Revenues N/A
Interest & Investment Income%
0%
Total 0%

Fundamentals

Market cap $1436926985
Assets
$294494000
ROA
20.01
Div./Share
$0.47

Financials

PASS

The financials pass all the three standards we check against.

Debt/A Cash/A (AR+C)/A
28.79%
28.66%
28.66%
< 33%
< 33%
< 50%
P
P
P
Debt/MC Cash/MC
5.9%
5.87%
< 30%
< 30%
P
P
Debt/24MC Cash/24MC AR/24MC
7.52%
28.66%
N/A
< 33%
< 33%
< 33%
P
P

Note: A = Assets | AR = Accounts Receivables | MC = Market cap | 24MC = 24 month avg. Market cap

✔ FTSE ✔ AAOIFI ✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses